bpc-157 availability Peptide | BPC-157 Synthetic Hormone BPC-157 Rapid | Fullscript
Description
Together with the absence of symptoms associated with IGF-1-mediated effects such as fluid retention, tissue edema, or impaired glucose tolerance, these results demonstrate that AOD-9604 does not activate the growth hormone/IGF-1 pathway and therefore functions through an entirely appetite-independent mechanism
Problem : Inconsistent blood levels = reduced effectiveness
Adverse symptoms can first be noted with the CBC test indicating large RBC or macrocytosisa folate and B12 deficiency
No evidence supports enhanced weight loss from adding b12 to semaglutide protocols
[Google Scholar] 20
